RemeGen Co., Ltd. — Capital/Financing Update 2011

Aug 23, 2011

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [236 x 58] intentionally omitted <==

Overseas Chinese Town (Asia) Holdings Limited 華僑城（亞洲）控股有限公司

(Incorporated in the Cayman Islands with limited liability)

(Stock Code: 03366)

INDICATIVE ANNOUNCEMENT

This announcement is made voluntarily by Overseas Chinese Town (Asia) Holdings Limited (the “ Company ”) pursuant to Rule 13.09 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the “ Listing Rules ”).

The Company is now in preliminary discussions with the controlling shareholder of the Company and/ or its associates in relation to a possible acquisition, and in connection of which, the Company may require to arrange fund-raising. If materialised, the possible acquisition may constitute a notifiable and connected transaction of the Company. However, as at the date of this announcement, no definitive agreement has been reached and therefore the possible acquisition may or may not proceed. Shareholders of the Company and potential investors should exercise extreme caution when dealing in the shares of the Company. The Company will make further announcement as and when required in accordance with the Listing Rules.

By order of the Board

Overseas Chinese Town (Asia) Holdings Limited Wang Xiaowen Chairman

Hong Kong, 23 August 2011

As at the date of this announcement, the board of directors of the Company (the “Directors”) comprises seven Directors, namely: Ms. Wang Xiaowen, Ms. Xie Mei and Mr. Zhou Guangneng as executive Directors, Mr. He Haibin as non-executive Director; Ms. Wong Wai Ling, Mr. Xu Jian and Mr. Lam Sing Kwong Simon as independent non-executive Directors.